Latest filing published 20 Jul 2026 for INCYTE CORP. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William Meury (board member) discloses dealings in 3 companies, chiefly Syndax Pharmaceuticals Inc, Incyte Corp and Karuna Therapeutics, Inc. Over a trading history stretching from 2 February 2022 to 16 July 2026, the count stands at 12 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 20 July 2026, the filings show a share grant in Incyte Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations